BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 14550831)

  • 1. Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence.
    Thor KB
    Urology; 2003 Oct; 62(4 Suppl 1):3-9. PubMed ID: 14550831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting serotonin and norepinephrine receptors in stress urinary incontinence.
    Thor KB
    Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S38-52. PubMed ID: 15302566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system control of the lower urinary tract: new pharmacological approaches to stress urinary incontinence in women.
    Thor KB; Donatucci C
    J Urol; 2004 Jul; 172(1):27-33. PubMed ID: 15201731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
    Jost W; Marsalek P
    Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What do we know about duloxetine's mode of action? Evidence from animals to humans.
    Schuessler B
    BJOG; 2006 May; 113 Suppl 1():5-9. PubMed ID: 16529563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural control of the urethra and development of pharmacotherapy for stress urinary incontinence.
    Fraser MO; Chancellor MB
    BJU Int; 2003 May; 91(8):743-8. PubMed ID: 12709086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of 5-HT receptors in treatment of overactive bladder.
    Khaled SM; Elhilali M
    Drugs Today (Barc); 2003 Aug; 39(8):599-607. PubMed ID: 14566383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of duloxetine, a norepinephrine and serotonin reuptake inhibitor, on sneeze-induced urethral continence reflex in rats.
    Miyazato M; Kaiho Y; Kamo I; Chancellor MB; Sugaya K; de Groat WC; Yoshimura N
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F264-71. PubMed ID: 18480175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobiology of stress urinary incontinence: new insights and implications for treatment.
    Cardozo L
    J Obstet Gynaecol; 2005 Aug; 25(6):539-43. PubMed ID: 16234136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress urinary incontinence in women: review and update on neurological control.
    Miller KL
    J Womens Health (Larchmt); 2005 Sep; 14(7):595-608. PubMed ID: 16181016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Duloxetine. A new preparation for patients with urinary incontinence].
    Walter S
    Ugeskr Laeger; 2005 Nov; 167(48):4553-5. PubMed ID: 16324435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for stress urinary incontinence.
    Castro-Diaz D; Amoros MA
    Curr Opin Urol; 2005 Jul; 15(4):227-30. PubMed ID: 15928510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine: a new approach for treating stress urinary incontinence.
    Moore K
    Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S53-62. PubMed ID: 15302567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence.
    Zinner NR
    Expert Opin Investig Drugs; 2003 Sep; 12(9):1559-66. PubMed ID: 12943499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of serotonin and noradrenaline in stress urinary incontinence.
    Michel MC; Peters SL
    BJU Int; 2004 Jul; 94 Suppl 1():23-30. PubMed ID: 15139860
    [No Abstract]   [Full Text] [Related]  

  • 16. Facilitatory neuromodulative effect of duloxetine on pudendal motor neurons controlling the urethral pressure: a functional urodynamic study in healthy women.
    Boy S; Reitz A; Wirth B; Knapp PA; Braun PM; Haferkamp A; Schurch B
    Eur Urol; 2006 Jul; 50(1):119-25. PubMed ID: 16455184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
    Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat.
    Thor KB; Katofiasc MA
    J Pharmacol Exp Ther; 1995 Aug; 274(2):1014-24. PubMed ID: 7636716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Update on medical treatment of female stress urinary incontinence].
    Yazbeck C; Dhainaut C; Batallan A; Thoury A; Madelenat P
    Gynecol Obstet Fertil; 2004 Jun; 32(6):556-61. PubMed ID: 15217571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability.
    Jung SY; Fraser MO; Ozawa H; Yokoyama O; Yoshiyama M; De Groat WC; Chancellor MB
    J Urol; 1999 Jul; 162(1):204-12. PubMed ID: 10379788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.